Short Term Outcome After Meniscectomy
1 other identifier
observational
150
1 country
1
Brief Summary
Short term outcome after meniscectomy: a meniscectomy is a very frequent performed orthopedically procedure. The short term outcome is favourable, but some patients keep having residual lesions after surgery. This prospective study examens the clinical outcome after meniscectomy using questionnaires (KOOS, VAS, SF-36, Tegner) (before the surgery, 3, 6 \& 12 months postoperative.) The investigators will also record the further treatment options for the people at risk.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2010
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2010
CompletedFirst Submitted
Initial submission to the registry
July 7, 2010
CompletedFirst Posted
Study publicly available on registry
July 8, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2015
CompletedDecember 14, 2022
December 1, 2022
5 years
July 7, 2010
December 13, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The clinical outcome (residual lesions) after a meniscectomy
KOOS-scale, Vas-scale, Tegner questionnaire, SF-36 questionnaire
12 months post-operative
Interventions
patients undergoing meniscectomy will be asked to complete the KOOS-scale,Vas-scale, Tegner questionnaire, SF-36 questionnaire pre-operatively and at 3, 6 and 12 months post-operatively
Eligibility Criteria
all the meniscectomy patients (male \& female, all ages)
You may qualify if:
- all the meniscectomy patients (male \& female, all ages)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital Ghent
Ghent, Belgium
Related Links
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Peter Verdonk, MD
University Hospital Ghent, Belgium
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 7, 2010
First Posted
July 8, 2010
Study Start
July 1, 2010
Primary Completion
July 1, 2015
Study Completion
July 1, 2015
Last Updated
December 14, 2022
Record last verified: 2022-12